ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,680, issued on Nov. 4, was assigned to Antev Ltd. (London).
"Reconstitutable teverelix-TFA composition" was invented by Finn Larsen (Hawick, Great Britain), Francois Boutignon (Clermont-Ferrand, France) and Guy Poland (Bristol, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a reconstitutable teverelix-TFA composition having a predefined molar ratio of teverelix to trifluoroacetate which is below the molar ratio required for microcrystal formation. Said composition remains stable during storage e.g., at a temperature around 2-8deg C. Upon reconstitution a fixed amount of trifluoroacetate can be added to s...